Exercise and Vascular Function in Haemodialysis Patients
The Effect of an Intra-dialytic Aerobic Exercise Intervention on Vascular Function in People Undergoing Maintenance Haemodialysis Therapy for Chronic Kidney Disease Stage 5. An Exploratory Study
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this study is to evaluate whether a three month intra-dialytic exercise programme improves arterial function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Nov 2012
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2012
CompletedFirst Posted
Study publicly available on registry
May 4, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedMarch 1, 2013
February 1, 2013
8 months
April 30, 2012
February 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brachial artery flow mediated dilatation
Brachial artery diameter is measured using vascular ultrasound. A cuff similar to that used for blood pressure is then inflated around the forearm for 5 minutes. Following cuff release vascular ultrasound is used to measure arterial dilation in response to reactive hyperaemia. Relative change in diameter provides a measure of endothelial function. Images are recorded over a period of 4-5 minutes post cuff release.
Baseline and 12 week follow-up
Secondary Outcomes (9)
Aortic pulse wave velocity
Baseline and three month follow-up
Maximal aerobic power
Baseline and three months
Timed up-and-go
Baseline and three month follow-up
Sit-to-stand 5
Baseline and 3 month follow-up
Non exercise questionnaire
Baseline and 3 month follow-up
- +4 more secondary outcomes
Study Arms (2)
Progressive muscle relaxation
SHAM COMPARATORAs well as usual care participants in the control arm will receive instruction in progressive muscle relaxation.
Aerobic exercise
ACTIVE COMPARATORIntervention -moderate intensity aerobic exercise.
Interventions
Participants in the intervention group will undertake moderate intensity aerobic exercise. Exercise modality will be recumbent cycling during the first two hours of haemodialysis sessions. Exercise prescription is set using a graded exercise test and anchored to a perceived level of exertion using the BORG scale. Training stimulus is maintained by the participant by increasing the cycling resistance when perceived exertion drops by one point at the current resistance level. Adherence and training volume is recorded during the intervention period.
This is a sequence of stretching and relaxation of the major muscle groups of the body. Participants are initially given detailed information regarding the technique and then provided with a recorded version which they listen to for 30-40 minutes during dialysis sessions. Participants in this group are offered the exercise programme at the end of three months.
Eligibility Criteria
You may qualify if:
- Stage 5 CKD patients (GFR \<15 mL/min) receiving maintenance haemodialysis therapy
- Male or female
- Aged \>18 years
- Written informed consent
You may not qualify if:
- Pregnancy
- Unstable cardiovascular conditions
- Recent cerebrovascular event
- Excess inter-dialytic weight gain
- Use of corticosteroids, anabolic therapies,
- Co-morbid catabolic conditions
- Serum potassium regularly \>6mmol/L
- Recent pulmonary thromboembolism
- Psychiatric illness including anxiety, mood and untreated eating disorders
- Infection or course of antibiotics within one month of study period.
- Dementia or severe cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen Margaret Universitylead
- British Kidney Patients Associationcollaborator
Study Sites (1)
Monklands Hospital
Airdrie, ML6 0JS, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tom Mercer, Professor
Queen Margaret University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Research Student
Study Record Dates
First Submitted
April 30, 2012
First Posted
May 4, 2012
Study Start
November 1, 2012
Primary Completion
July 1, 2013
Study Completion
February 1, 2014
Last Updated
March 1, 2013
Record last verified: 2013-02